Catal­ent bags a Ger­man stem cell de­vel­op­er to build its next-gen ther­a­peu­tics wing

An­oth­er day, an­oth­er ac­qui­si­tion for CD­MO gi­ant Catal­ent. The New Jer­sey firm has now bought out Ger­many’s Rhein­Cell Ther­a­peu­tics, a spe­cial­ist in hu­man in­duced pluripo­tent …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER